Menghua Xiong | Nanomedicine | Best Researcher Award

Posted on by Pencis

Prof. Menghua Xiong | Nanomedicine | Best Researcher Award

Prof. Menghua Xiong, South China University of Technology, China

Prof. Menghua Xiong is a professor at the School of Biomedical Sciences and Engineering at South China University of Technology, Guangzhou, China. He earned his B.E. and Ph.D. in Polymer Science and Engineering from the University of Science and Technology of China (USTC), where he worked under the mentorship of Prof. Jun Wang. Prof. Xiong completed postdoctoral research at the University of Illinois at Urbana-Champaign in the Department of Materials Science and Engineering, working with Prof. Jianjun Cheng. His research focuses on advanced polymers, drug delivery systems, and biomedical materials, contributing significantly to the development of novel materials for medical applications.

Author Profile

Orcid Profile

Google Scholar

🎓EARLY ACADEMIC PURSUITS:

Prof. Menghua Xiong began his academic journey in September 2003 at the University of Science and Technology of China (USTC), where he earned his Bachelor of Engineering (B.E.) degree in Polymer Science and Engineering in July 2007. He continued his studies at USTC, completing a Ph.D. in Polymer Science and Engineering under the guidance of Prof. Jun Wang from September 2007 to June 2013.

🏫PROFESSIONAL ENDEAVORS:

After completing his doctoral studies, Prof. Xiong pursued postdoctoral research at the University of Illinois at Urbana-Champaign (UIUC) from July 2013 to December 2017. During this period, he worked in the Department of Materials Science and Engineering under the mentorship of Prof. Jianjun Cheng, gaining valuable experience in materials science and engineering. In January 2018, Prof. Xiong joined the School of Biomedical Sciences and Engineering at the Guangzhou International Campus of South China University of Technology as a professor, where he currently holds a faculty position.

🔬CONTRIBUTIONS AND RESEARCH FOCUS ON NANOMEDICINE:

Prof. Xiong’s research focuses on polymer science and biomedical engineering, with significant contributions to the development of advanced materials for biomedical applications. His work spans areas such as the synthesis and design of novel polymers, drug delivery systems, and biomaterials for medical use. He has made noteworthy advancements in the intersection of materials science, biomedical engineering, and polymer chemistry.

📈IMPACT AND INFLUENCE:

Prof. Xiong has been influential in the field of polymer science and biomedical engineering, contributing to key developments in the design of functional materials for drug delivery and tissue engineering. His research has led to innovations that have applications in the medical field, impacting drug delivery systems and materials used in medical devices. He is also known for his collaborations with international researchers and for mentoring future scientists in the field.

📚ACADEMIC CITATIONS:

Prof. Xiong has received recognition for his research in terms of academic citations, with his work being referenced by researchers in polymer science, materials engineering, and biomedical fields. His publications have contributed to the advancement of knowledge in areas such as polymer synthesis, biomedical materials, and drug delivery technologies.

🌟LEGACY AND FUTURE CONTRIBUTIONS:

Prof. Xiong’s legacy is marked by his dedication to advancing the field of polymer science and biomedical engineering. His future contributions are expected to focus on further innovations in biomaterials, particularly in areas like personalized medicine, advanced drug delivery systems, and tissue engineering. As a mentor and researcher, Prof. Xiong continues to influence the development of the next generation of scientists and researchers in these fields.

🌍CONCLUSION:

Prof. Menghua Xiong is a prominent figure in the fields of polymer science and biomedical engineering, with a strong academic foundation from the University of Science and Technology of China (USTC) and valuable postdoctoral experience at the University of Illinois at Urbana-Champaign. His research contributions, particularly in the areas of polymer synthesis, drug delivery, and biomedical materials, have made a significant impact on advancing medical technologies. As a professor at South China University of Technology, Prof. Xiong continues to shape the future of biomedical sciences through his innovative work and mentorship of the next generation of researchers.

CITATIONS:

Citations –  4286
h-index –  27
i10-index –  29

TOP NOTABLE PUBLICATIONS

The Relationship between In Vivo Toxicity and Responsive pH in Transistor‐Like pH‐Sensitive Nanodetergents

Authors: Meng-Hua Xiong

Journal: Small Methods

Year: 2024

Helicity-directed recognition of bacterial phospholipid via radially amphiphilic antimicrobial peptides

Authors: Meng-Hua Xiong

Journal: Science Advances

Year: 2024

Stimuli‐responsive linkers and their application in molecular imaging

Authors: Meng-Hua Xiong

Journal: Exploration

Year: 2024

Stimuli-responsive linkers and their application in molecular imaging (Preprint)

Authors: Meng-Hua Xiong

Journal: Exploration (Preprint)

Year: 2023

pH Window for High Selectivity of Ionizable Antimicrobial Polymers toward Bacteria

Authors: Meng-Hua Xiong

Journal: ACS Applied Materials & Interfaces

Year: 2023

A helical oncolytic polypeptide with potent membranolytic activity for cancer therapy

Authors: Meng-Hua Xiong

Journal: Biomaterials Science

Year: 2023

Nanoblock-mediated selective oncolytic polypeptide therapy for triple-negative breast cancer

Authors: Meng-Hua Xiong

Journal: Theranostics

Year: 2023

A transistor-like pH-sensitive nanodetergent for selective cancer therapy

Authors: Meng-Hua Xiong

Journal: Nature Nanotechnology

Year: 2022

Biomedical polymers: synthesis, properties, and applications

Authors: Meng-Hua Xiong

Journal: Science China Chemistry

Year: 2022

Modulation of Conformational Transition of Polypeptides under Slightly Acidic Environment

Authors: Meng-Hua Xiong

Journal: Chinese Journal of Chemistry

Year: 2022

Xingang Li | harmacology | Best Research Article Award

Posted on by Pencis

Prof. Xingang Li | pharmacology | Best Research Article Award 

Prof. Xingang Li, Department of Pharmacy, Beijing Friendship Hospital, China

Prof. Xingang Li is the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, China, where he also serves as a Chief Pharmacist, Professor, and Ph.D. Supervisor. An expert in quantitative pharmacology and genetic pharmacology, Prof. Li has published over 50 articles in top-tier journals, with more than 1000 citations and an H-index of 20. He is an External Expert at the National Center for Drug Evaluation, a member of multiple prestigious pharmacological committees, and a reviewer for leading journals such as Biomaterials and Clin Transl Med. His research focuses on personalized medicine, drug delivery systems, and epigenetic influences on pharmacodynamics.

Profile:

Orcid Profile

🏥 Current Positions:

Prof. Li Xingang serves as the Deputy Director of the Pharmacy Department at Beijing Friendship Hospital, where he is also the Chief Pharmacist. As a Professor and Ph.D. Supervisor, he is instrumental in nurturing future generations of pharmacists and researchers. His leadership role involves overseeing advanced pharmacological practices, mentoring young scientists, and ensuring cutting-edge drug evaluation and management systems. With a strong emphasis on precision medicine, Prof. Li combines clinical expertise and research excellence to address pressing healthcare challenges.

📚 Academic Background:

Prof. Li has an extensive academic background, which underpins his outstanding contributions to quantitative pharmacology and genetic pharmacology. His role as an External Expert at the National Center for Drug Evaluation and Review Expert for the Beijing Science and Technology Plan Project showcases his authority in the field. His memberships in prestigious committees, such as the Quantitative Pharmacology Committee of the Chinese Pharmacological Society and the Epigenetics Committee, reflect his deep commitment to advancing pharmaceutical sciences.

🧪 Research Interests and Achievements:

Quantitative Pharmacology: Prof. Li has a keen interest in developing predictive models to optimize drug efficacy and safety, leveraging mathematical frameworks to personalize treatment.

Genetic Pharmacology: His research focuses on exploring genetic factors that influence drug metabolism and efficacy, aiming to enhance personalized medicine approaches.

Prof. Li has successfully led over ten major projects, including initiatives funded by the Ministry of Science and Technology, the National Natural Science Foundation, and the Beijing Science and Technology Plan. These projects address critical areas like drug delivery systems, personalized pharmacotherapy, and genetic determinants of drug response.

🖋️ Publication Achievements:

Prof. Li’s academic rigor is evident in his extensive publication record, with over 50 articles in Q1 journals such as Nano Letters, Acta Pharmacologica Sinica, and Phytomedicine. His works have been cited more than 1000 times, and he holds an impressive H-index of 20, reflecting his impact on the scientific community. His publications explore innovative drug delivery systems, genetic biomarkers, and clinical pharmacokinetics, contributing significantly to global pharmacological advancements.

🏆 Scholarships and Awards:

Prof. Li has received numerous accolades for his contributions:

  • Servier Young Hospital Pharmacy Award, China Pharmaceutical Society
  • Outstanding Pharmacist Award, Beijing Pharmaceutical Society
  • Recognized for Outstanding Papers and groundbreaking research, reflecting his excellence in clinical pharmacy and translational research.

🧑‍🔬 Professional Associations and Editorial Roles:

Prof. Li is actively involved in professional organizations, including the Chinese Pharmacological Society and the China Pharmaceutical Education Association. He serves as an Editorial Board Member for journals such as China Hospital Pharmacy Evaluation and Analysis and Chinese Pharmacy, ensuring the dissemination of high-quality research.

As a Reviewer for prestigious journals like Biomaterials and Clin Transl Med, he evaluates cutting-edge studies in pharmacology, bioinformatics, and materials science, further contributing to his field’s knowledge base.

💻 Bioinformatics and Laboratory Experience:

Prof. Li integrates bioinformatics tools into his research to analyze complex datasets and identify genetic markers associated with drug response. His laboratory is equipped with advanced technologies for pharmacokinetic modeling, epigenetic profiling, and drug formulation analysis, enabling groundbreaking discoveries.

🎓 Training, Workshops, and Oral Presentations:

Prof. Li regularly participates in international conferences, presenting his research findings and engaging with global experts. His oral presentations at prestigious forums highlight advancements in therapeutic drug monitoring (TDM), anesthesiology pharmacy, and intravenous preparation management, solidifying his reputation as a thought leader.

✅ Tasks Completed as a Researcher:

Prof. Li has successfully completed tasks ranging from designing clinical trials to publishing high-impact research. His ability to translate laboratory findings into practical solutions for patient care exemplifies his commitment to improving healthcare outcomes.

🌟 Success Factors and Key Contributions:

Prof. Li’s success stems from his:

  • Collaborative approach in multidisciplinary projects
  • Innovative methodologies in drug evaluation and genetic research
  • Dedication to mentoring young professionals and fostering academic growth

🔬 Ongoing Research Projects:

His current projects delve into:

  • Advanced drug delivery systems to enhance treatment efficacy
  • Epigenetic influences on pharmacodynamics
  • Personalized medicine approaches using genetic profiling

🔍 Conclusion:

Prof. Li Xingang is a distinguished leader in the field of pharmacology, whose contributions span clinical excellence, innovative research, and impactful publications. His work in quantitative and genetic pharmacology, combined with his dedication to mentoring and professional engagement, sets him apart as a visionary in healthcare. His achievements and ongoing endeavors continue to shape the future of precision medicine and pharmacological sciences.

Top Notable Publications:

1. Immune-Related Colitis Induced by Camrelizumab: A Case Report

Authors: Xingang Li

Journal: Journal of Inflammation Research

Year: 2023

2. Population pharmacokinetics and dosing optimisation of imipenem in critically ill patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice-

Year: 2023

3. Association of Alcohol Drinking and Helicobacter pylori Infection: A Meta-analysis

Authors: Xingang Li

Journal: Journal of Clinical Gastroenterology

Year: 2023

4. Population pharmacokinetics of oxcarbazepine 10-monohydroxy derivative in Chinese adult epileptic patients

Authors: Xingang Li

Journal: European Journal of Hospital Pharmacy: Science and Practice

Year: 2022

5. Association between GNAQ Gene DNA Methylation and Vascular Recurrence in Patients with Acute Ischemic Stroke or Transient Ischemic Attack

Authors: Xingang Li

Journal: Cerebrovascular Diseases (Basel, Switzerland)

Year: 2022

6. Impact of Azithromycin on Forsythiaside Pharmacokinetics in Rats: A Population Modeling Method

Authors: Xingang Li

Journal: Current Medical Science

Year: 2022

7. Docetaxel population pharmacokinetic modelling and simulation in Chinese cancer patients

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

8. Development of a multivariable clinical prediction model for liposomal doxorubicin-induced cardiotoxicity in adult breast cancer patients: A retrospective multicenter study

Authors: Xingang Li

Journal: Annals of Translational Medicine

Year: 2022

9. Population pharmacokinetics of methotrexate in pediatric patients with acute lymphoblastic leukemia and malignant lymphoma

Authors: Xingang Li

Journal: Xenobiotica

Year: 2022

10. The clinical population pharmacokinetics, metabolomics, and therapeutic analysis of alkaloids from Alstonia scholaris leaves in acute bronchitis patients

Authors: Xingang Li

Journal: Phytomedicine

Year: 2022